EX-99.77C VOTES 3 ex77c.htm EX.99.77C

Item 77C: The European Equity Fund, Inc.
The Annual Meeting of Stockholders (the "Meeting") of The European Equity Fund, Inc. was held on June 27, 2017.  The Meeting was adjourned until, and reconvened on, June 30, 2017 to permit the solicitation of additional votes with respect to a proposal.  At the close of business on May 15, 2017, the record date for the determination of stockholders entitled to vote at the Meeting, there were issued and outstanding 8,079,560 shares of the Fund's common stock, each share being entitled to one vote, constituting all of the Fund's outstanding voting securities.  At the Meeting, the holders of 6,074,727 shares of the Fund's common stock were represented in person or by proxy, constituting a quorum.  At the Meeting, the following matters were voted upon by the stockholders.  The resulting votes are presented below:

1.
To elect three (3) Class III Directors, each to serve for a term of three years and until his successor is elected and qualifies.

Number of Votes

 
For 
Withheld
Mr. Christian H. Strenger
5,431,503
643,225
Dr. Wolfgang Leoni
5,467,746
606,982
Dr. Kenneth C. Froewiss
5,463,468
611,260
2.
To elect one (1) Class II Director, to serve for a term of two years and until his successor is elected and qualifies.
Number of Votes

 
For 
Withheld
Dr. Christopher Pleister
5,467,661
607,067

3.
To ratify the appointment by the Audit Committee and the Board of Directors of PricewaterhouseCoopers LLP, an independent public accounting firm, as independent auditors for the fiscal year ending December 31, 2017.

Number of Votes

For
Against
Abstain
6,047,927
35,258
45,242

4.
To change the Fund's investment objective from seeking "long-term capital appreciation through investment primarily in equity or equity-linked securities of issuers domiciled in countries that are members of the European Union" to seeking "long-term capital appreciation through investment primarily in equity or equity-linked securities of issuers domiciled in Europe;" and to change the Fund's corresponding fundamental investment policy to provide that, "[u]nder normal circumstances, at least 80% of the Fund's net assets (plus any assets funded with leverage) will be invested in equity or equity-linked securities of issuers domiciled in Europe."

Number of Votes

For
Against
Abstain
4,133,777
566,052
40,842

As of June 30, 2017, the Fund's Board of Directors is as follows:


Christian H. Strenger
Chairman and Director
(interested)
since 1986
Class III – term expires 2020
Dr. Wilhelm Bender
 
Director
(non-interested)
since 2013
Class I – term expires 2018
Detlef Bierbaum
 
Director
(non-interested)
since 1986
Class I – term expires 2018
Ambassador Richard R. Burt
Director
(non-interested)
since 2000
Class II – term expires 2019
Walter C. Dostmann
 
Director
(non-interested)
Since 2015
Class I – term expires 2018
Dr. Kenneth C. Froewiss
Director
(non-interested)
since 2017
Class III – term expires 2020
Dr. Wolfgang Leoni
 
Director
(non-interested)
since 2017
Class III – term expires 2020
Dr. Christopher Pleister
Director
(non-interested)
since 2016
Class II – term expires 2019